StockData
BioCryst Pharmaceuticals Inc logo

BioCryst Pharmaceuticals Inc (BCRX) stock

BCRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/30
$7.30−0.20 (-2.67%)

Close on Nov 18, 2026Market cap $1.87BP/E –Yield –

BioCryst Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BioCryst Pharmaceuticals's price to book ratio was 44.7× on Jan 29, 2021, against 15.5× a year earlier. Over the last 5 years it ranged from 3.1× to 392.8×, with a median of 13.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Jan 29, 202144.7×+5.6
2020Dec 31, 202039.1×+23.6
2019Jul 31, 201915.5×+3.4
2018Dec 31, 201812.1×+7.3
2017Dec 29, 20174.8×−112.1
2016Dec 30, 2016116.9×+105.1
2015Dec 31, 201511.8×+1.3
2014Dec 31, 201410.5×−121.2
2013Dec 31, 2013131.7×+124.3
2012Dec 31, 20127.4×+7.4
2011Dec 30, 20110.0×–

More BioCryst Pharmaceuticals figures

See a number that looks wrong?